5 Fibromyalgia Clinical Trials in Stanford, CA (2026)

Q: How do I join a clinical trial in Stanford?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you.

Recruiting Fibromyalgia Studies in Stanford

NCT01915511Recruiting

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the registry expanded to inc...

Stanford, CA3,000 participantsDuke University

View Study Details

NCT05943535Recruiting

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period....

Stanford, CA698 participantsUnited Therapeutics

View Study Details

NCT07652658Recruiting

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

This Phase IIb study aims to evaluate the efficacy, safety, and tolerability of 3 doses of AZD8965 treatment compared to placebo in participants with IPF, including those on antifibrotic therapy (nint...

Stanford, CA359 participantsAstraZeneca

View Study Details

NCT05386615Recruiting

Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids

The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids....

Stanford, CA200 participantsInSightec

View Study Details

NCT05988463Recruiting

Dose-Escalation Study of Artesunate Patients With IPF

Idiopathic Pulmonary Fibrosis (IPF) is a chronic progressive fibrotic lung disease resulting in increasing shortness of breath, cough, and low oxygen levels as a result of lung tissue scarring . This ...

Stanford, CA15 participantsJoseph C. Wu

View Study Details

About Fibromyalgia Clinical Trials in Stanford

Fibromyalgia is a condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive difficulties. It affects about 2-4% of the population, predominantly women. Treatment includes medications, exercise, stress management, and cognitive behavioral therapy.

There are currently 5 fibromyalgia clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 4,272 participants. Research is being sponsored by Duke University, United Therapeutics, AstraZeneca and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fibromyalgia Clinical Trials in Stanford — FAQ

Are there fibromyalgia clinical trials in Stanford?

Yes, there are 5 fibromyalgia clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Stanford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.

Are clinical trials in Stanford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.

What fibromyalgia treatments are being tested?

The 5 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for fibromyalgia.

Data updated July 13, 2026 from ClinicalTrials.gov